NCT01028768View on ClinicalTrials.gov

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Renal Impairment
Interventions
DRUG

Teduglutide

10 mg, one-time subcutaneous

Trial Locations (1)

78467

Nycomed GmbH, Konstanz

Sponsors

Lead Sponsor

Nycomed

Collaborators (1)

NPS Pharma
All Listed Sponsors
collaborator

NPS Pharma

INDUSTRY

lead

Nycomed

INDUSTRY

NCT01028768 - Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function | Biotech Hunter | Biotech Hunter